MongoDB shows bullish technicals but faces weakened fundamentals with declining growth. See why now may be the time to sell ...

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

The US dollar is trying to recover on Friday, as recent selling pressure has been strong, but at this point in time, it looks like the market is going to see a bit of recovery.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Gold (XAU/USD) is currently trading at $2,931.60, up 0.02%, as it hovers above the critical pivot point of $2,923.15. The price remains supported by the 50-EMA at $2,902.89, indicating ongoing bullish ...

Tata Consumer Products Ltd has maintained a strong support level above the 20-DMA since January 2025, and is now close to the ...

After weeks of bullish effort, GBP/USD is finally back above the 50-day Exponential Moving Average (EMA) near the 1.2500 ...

The Global Vial Adaptors for Reconstitution Drug market is poised for substantial growth, reflecting strong financial projections and industry expansion. In 2023, the market was valued at USD 2,186.69 ...

The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion.

The GBP/JPYgained sharply after upbeat UK GDP data. It hit an intraday high of 1912.82 and is currently trading around 192.78 ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance” or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

A new evaluation index system, developed using the Appropriateness Evaluation Protocol (AEP) framework within the Enhanced ...